Report Highlights
Here are the key highlights from the report:
- Feed Scope: Companies engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of Neurological disorders.
Companies included in the report
Companies engaged in R&D for developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of Neurological disorders.Top Neurology Companies
The top 3 companies in Neurology are Jazz Pharmaceuticals, Biogen and PTC Therapeutics.Recent Investments
Recent noteworthy Investments in Neurology sector include:- $650M, Series E round in Neuralink on May 27, 2025
- $372M, Series D round in MapLight on Jul 18, 2025
- $321M, Series D round in Kriya Therapeutics on Jul 31, 2025
Top Acquisitions
- Notable acquisitions in the Neurology sector include Xycota being acquired by Nextel Medical on Aug 05, 2026, AtaiBeckley acquired by Lilly on Jul 16, 2026 and 4E Therapeutics acquired by Lilly on Jun 16, 2026.
Report Preview
__uN1AACck6cIUI3FmQDCwC.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__Z2TSJgw59_ZmGgxnlNfev.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__TU0HSwOD24hb7yUCCg4S0.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__QTyq8lBZ7wLbbX-tdXoee.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
